Uveitis	B:C0042164
in	O
children	O

The	O
review	O
provides	O
updates	O
on	O
novel	O
risk	O
markers	O
for	O
the	O
development	O
of	O
pediatric	O
inflammatory	B:C0042164
uveitis	I:C0042164
and	O
a	O
severe	O
disease	I:C0242656
course	I:C0242656
,	O
on	O
treatment	O
of	O
refractory	O
disease	I:C1514815
,	O
and	O
on	O
the	O
measurement	O
of	O
visual	O
outcomes	O
.	O

The	O
review	O
provides	O
updates	O
on	O
novel	O
risk	O
markers	O
for	O
the	O
development	O
of	O
pediatric	O
inflammatory	O
uveitis	I:C0042164
and	O
a	O
severe	B:C0242656
disease	I:C0242656
course	I:C0242656
,	O
on	O
treatment	O
of	O
refractory	O
disease	I:C1514815
,	O
and	O
on	O
the	O
measurement	O
of	O
visual	O
outcomes	O
.	O

The	O
review	O
provides	O
updates	O
on	O
novel	O
risk	O
markers	O
for	O
the	O
development	O
of	O
pediatric	O
inflammatory	O
uveitis	I:C0042164
and	O
a	O
severe	O
disease	I:C0242656
course	I:C0242656
,	O
on	O
treatment	B:C0087111
of	O
refractory	O
disease	I:C1514815
,	O
and	O
on	O
the	O
measurement	O
of	O
visual	O
outcomes	O
.	O

The	O
review	O
provides	O
updates	O
on	O
novel	O
risk	O
markers	O
for	O
the	O
development	O
of	O
pediatric	O
inflammatory	O
uveitis	I:C0042164
and	O
a	O
severe	O
disease	I:C0242656
course	I:C0242656
,	O
on	O
treatment	O
of	O
refractory	B:C1514815
disease	I:C1514815
,	O
and	O
on	O
the	O
measurement	O
of	O
visual	O
outcomes	O
.	O

There	O
are	O
several	O
new	O
genetic	B:C0017393
markers	I:C0017393
,	O
biomarkers	O
,	O
and	O
clinical	O
factors	O
that	O
may	O
influence	O
a	O
child	O
's	O
uveitis	O
disease	O
course	I:C0242656
.	O

There	O
are	O
several	O
new	O
genetic	O
markers	I:C0017393
,	O
biomarkers	B:C0005516
,	O
and	O
clinical	O
factors	O
that	O
may	O
influence	O
a	O
child	O
's	O
uveitis	O
disease	O
course	I:C0242656
.	O

There	O
are	O
several	O
new	O
genetic	O
markers	I:C0017393
,	O
biomarkers	O
,	O
and	O
clinical	O
factors	O
that	O
may	O
influence	O
a	O
child	O
's	O
uveitis	B:C0042164
disease	O
course	I:C0242656
.	O

There	O
are	O
several	O
new	O
genetic	O
markers	I:C0017393
,	O
biomarkers	O
,	O
and	O
clinical	O
factors	O
that	O
may	O
influence	O
a	O
child	O
's	O
uveitis	O
disease	B:C0242656
course	I:C0242656
.	O

It	O
is	O
important	O
to	O
identify	O
children	O
at	O
risk	O
for	O
poor	O
visual	O
outcomes	O
and	O
who	O
are	O
refractory	O
to	O
traditional	B:C3650840
therapy	I:C3650840
.	O

Racial	B:C0243095
disparities	I:C0243095
have	O
recently	O
been	O
reported	O
.	O

Racial	O
disparities	I:C0243095
have	O
recently	O
been	O
reported	B:C0684224
.	O

We	O
describe	O
agents	B:C0450442
of	O
potential	O
benefit	O
.	O

In	O
addition	O
,	O
we	O
discuss	O
the	O
importance	O
of	O
patient	B:C2987124
reported	I:C2987124
outcomes	I:C2987124
in	O
this	O
population	O
.	O

Uveitis	B:C0042164
can	O
lead	O
to	O
vision	O
-	I:C0009566
threatening	I:C0009566
complications	I:C0009566
.	O

Uveitis	O
can	O
lead	O
to	O
vision	B:C0009566
-	I:C0009566
threatening	I:C0009566
complications	I:C0009566
.	O

Timely	B:C0087111
and	I:C0087111
aggressive	I:C0087111
treatment	I:C0087111
of	O
children	O
identified	O
to	O
be	O
at	O
risk	O
for	O
a	O
severe	O
uveitis	I:C0242656
course	I:C0242656
may	O
lead	O
to	O
improved	O
outcomes	O
.	O

Timely	O
and	I:C0087111
aggressive	I:C0087111
treatment	I:C0087111
of	O
children	O
identified	O
to	O
be	O
at	O
risk	O
for	O
a	O
severe	B:C0242656
uveitis	I:C0242656
course	I:C0242656
may	O
lead	O
to	O
improved	O
outcomes	O
.	O

